Attalla K - Search Results

1

The evolution of bladder cancer genomics: What have we learned and how can we use it?

Audenet F, Attalla K, Sfakianos JP. Audenet F, et al. Among authors: attalla k. Urol Oncol. 2018 Jul;36(7):313-320. doi: 10.1016/j.urolonc.2018.02.017. Epub 2018 Mar 21. Urol Oncol. 2018. PMID: 29573965 Review.

2

Leiomyosarcoma of the Inferior Vena Cava With Kidney Invasion.

Brewer K, Attalla K, Husain F, Tsao CK, Badani KK, Sfakianos JP. Brewer K, et al. Among authors: attalla k. Urol Case Rep. 2016 Sep 23;9:33-6. doi: 10.1016/j.eucr.2016.08.011. eCollection 2016 Nov. Urol Case Rep. 2016. PMID: 27679758 Free PMC article.

3

Robotic-assisted radical cystectomy versus open radical cystectomy for management of bladder cancer: review of literature and randomized trials.

Attalla K, Kent M, Waingankar N, Mehrazin R. Attalla K, et al. Future Oncol. 2017 Jun;13(13):1195-1204. doi: 10.2217/fon-2017-0004. Epub 2017 Jun 26. Future Oncol. 2017. PMID: 28650267

4

Demographic and socioeconomic predictors of treatment delays, pathologic stage, and survival among patients with penile cancer: A report from the National Cancer Database.

Attalla K, Paulucci DJ, Blum K, Anastos H, Moses KA, Badani KK, Spiess PE, Sfakianos JP. Attalla K, et al. Urol Oncol. 2018 Jan;36(1):14.e17-14.e24. doi: 10.1016/j.urolonc.2017.09.014. Epub 2017 Oct 12. Urol Oncol. 2018. PMID: 29031418 Free PMC article.

5

Current Role of Checkpoint Inhibitors in Urologic Cancers.

Attalla K, Sfakianos JP, Galsky MD. Attalla K, et al. Cancer Treat Res. 2018;175:241-258. doi: 10.1007/978-3-319-93339-9_11. Cancer Treat Res. 2018. PMID: 30168125

6

Prospective implementation of a nonopioid protocol for patients undergoing robot-assisted radical cystectomy with extracorporeal urinary diversion.

Audenet F, Attalla K, Giordano M, Pfail J, Lubin MA, Waingankar N, Gainsburg D, Badani KK, Sim A, Sfakianos JP. Audenet F, et al. Among authors: attalla k. Urol Oncol. 2019 May;37(5):300.e17-300.e23. doi: 10.1016/j.urolonc.2019.02.002. Epub 2019 Feb 16. Urol Oncol. 2019. PMID: 30777392

7

Management of distal ureter and bladder cuff at the time of nephroureterectomy: surgical techniques and predictors of outcome.

Attalla K, Patnaik S, Vellos T, Mehrazin R. Attalla K, et al. Future Oncol. 2019 Jul;15(20):2385-2393. doi: 10.2217/fon-2019-0064. Epub 2019 Jun 25. Future Oncol. 2019. PMID: 31237445 Review.

8

Prolonged hormonal therapy and external beam radiation independently increase the risk of Persistent Hypogonadism in men treated with prostate brachytherapy.

Attalla K, Sagalovich D, Marqueen KE, Sfakianos JP, Tewari AK, Badani KK, Stock RG, Stone NN. Attalla K, et al. Brachytherapy. 2020 Mar-Apr;19(2):210-215. doi: 10.1016/j.brachy.2019.12.002. Epub 2020 Jan 17. Brachytherapy. 2020. PMID: 31959519

9

TIM-3 and TIGIT are possible immune checkpoint targets in patients with bladder cancer.

Attalla K, Farkas AM, Anastos H, Audenet F, Galsky MD, Bhardwaj N, Sfakianos JP. Attalla K, et al. Urol Oncol. 2022 Sep;40(9):403-406. doi: 10.1016/j.urolonc.2020.06.007. Epub 2020 Jul 12. Urol Oncol. 2022. PMID: 32665122 Free PMC article. Review.

10

Outcomes from a prospectively implemented protocol using apixaban after robot-assisted radical cystectomy.

Rich JM, Elkun Y, Geduldig J, Lavallee E, Mehrazin R, Attalla K, Wiklund P, Sfakianos JP. Rich JM, et al. Among authors: attalla k. BJU Int. 2023 Oct;132(4):390-396. doi: 10.1111/bju.16036. Epub 2023 May 11. BJU Int. 2023. PMID: 37186173

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

48 results

Search Page

Filters